Kallikrein 5 (KLK5) (N-Term) Peptide
-
- Antigène Tous les produits Kallikrein 5 (KLK5)
- Kallikrein 5 (KLK5)
- Protein Region
- N-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-KLK5 antibody (Catalog #: ARP45010_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- Kallikrein 5 (KLK5)
- Synonymes
- KLK-L2 Peptide, KLKL2 Peptide, SCTE Peptide, 1110030O19Rik Peptide, KAL Peptide, KALA Peptide, Klk1 Peptide, Klk5 Peptide, RATKALA Peptide, kallikrein related peptidase 5 Peptide, kallikrein related-peptidase 5 Peptide, kallikrein 5-like Peptide, KLK5 Peptide, Klk5 Peptide, Klk5l Peptide
- Sujet
-
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one
Alias Symbols: KLK-L2, KLKL2, SCTE
Protein Interaction Partner: DSG1,SERPINA1
Protein Size: 293 - Poids moléculaire
- 25 kDa
- ID gène
- 25818
- NCBI Accession
- NM_001077491, NP_001070959
- UniProt
- Q9Y337
-